Intuitive Surgical (NASDAQ:ISRG) EVP Myriam Curet Sells 104 Shares of Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Myriam Curet sold 104 shares of the stock in a transaction on Wednesday, December 10th. The stock was sold at an average price of $559.90, for a total transaction of $58,229.60. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

Myriam Curet also recently made the following trade(s):

• On Monday, November 10th, Myriam Curet sold 105 shares of Intuitive Surgical stock. The stock was sold at an average price of $560.00, for a total value of $58,800.00.
• On Tuesday, October 28th, Myriam Curet sold 7,562 shares of Intuitive Surgical stock. The shares were sold at an average price of $548.43, for a total value of $4,147,227.66.
• On Wednesday, October 29th, Myriam Curet sold 125 shares of Intuitive Surgical stock. The stock was sold at an average price of $543.00, for a total value of $67,875.00.

Intuitive Surgical Stock Down 1.3%

ISRG stock traded down $7.48 during midday trading on Thursday, hitting $548.44. 258,820 shares of the company traded hands, compared to its average volume of 2,077,931. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00. The stock has a market capitalization of $196.60 billion, a price-to-earnings ratio of 72.53, a price-to-earnings-growth ratio of 5.13 and a beta of 1.68. The business has a 50 day simple moving average of $525.73 and a 200-day simple moving average of $505.69.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. The business had revenue of $2.51 billion for the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. Intuitive Surgical’s revenue was up 22.9% compared to the same quarter last year. During the same period last year, the business posted $1.84 EPS. Equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Institutional Trading of Intuitive Surgical

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Aaron Wealth Advisors LLC boosted its holdings in Intuitive Surgical by 0.8% during the second quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider’s stock valued at $1,374,000 after purchasing an additional 19 shares in the last quarter. Prosperity Consulting Group LLC lifted its position in shares of Intuitive Surgical by 0.5% during the 3rd quarter. Prosperity Consulting Group LLC now owns 4,033 shares of the medical equipment provider’s stock worth $1,804,000 after buying an additional 19 shares during the period. Evergreen Capital Management LLC boosted its stake in Intuitive Surgical by 0.5% in the 1st quarter. Evergreen Capital Management LLC now owns 4,288 shares of the medical equipment provider’s stock valued at $2,124,000 after buying an additional 20 shares in the last quarter. Rise Advisors LLC boosted its stake in Intuitive Surgical by 5.6% in the 1st quarter. Rise Advisors LLC now owns 378 shares of the medical equipment provider’s stock valued at $187,000 after buying an additional 20 shares in the last quarter. Finally, Rossmore Private Capital grew its position in Intuitive Surgical by 2.0% in the third quarter. Rossmore Private Capital now owns 998 shares of the medical equipment provider’s stock valued at $446,000 after acquiring an additional 20 shares during the period. Institutional investors own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms recently weighed in on ISRG. Evercore ISI boosted their price objective on Intuitive Surgical from $450.00 to $540.00 in a research report on Wednesday, October 22nd. Hsbc Global Res raised Intuitive Surgical to a “strong-buy” rating in a research report on Thursday, October 23rd. UBS Group set a $600.00 target price on shares of Intuitive Surgical and gave the stock a “neutral” rating in a research report on Thursday, October 23rd. Leerink Partners upped their target price on shares of Intuitive Surgical from $593.00 to $600.00 and gave the company an “outperform” rating in a research note on Wednesday, October 22nd. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Intuitive Surgical in a research report on Friday, October 31st. Two research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $606.54.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.